Fulgent Genetics, Inc. (FLGT) Q1 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Fulgent Genetics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:03.295 reminder, this conference is being recorded. 00:00:03.295 -- 00:00:07.301 It's now my pleasure to turn the call over to Melanie Solomon, Investor Relations. 00:00:07.301 -- 00:00:07.942 Please go ahead. 00:00:07.942 -- 00:00:09.942 Thank 00:00:10.325 -- 00:00:15.112 you, Kevin. Good morning, and welcome to the Fulgen First Quarter 2025 Financial Results 00:00:15.112 -- 00:00:19.938 Conference Call. On the call are Ming Shai, Chief Executive Officer, Paul Kim, Chief 00:00:19.938 -- 00:00:24.145 Financial Officer, and Brandon Perthews, Chief Commercial Officer. 00:00:24.145 -- 00:00:27.449 The company's press release discussing the financial results is available on the Investor 00:00:27.449 -- 00:00:31.431 Relations section of the company's website, ir.fulgengenetics.com. 00:00:31.714 -- 00:00:35.379 A replay of this call will be available shortly after the call concludes on the Investor 00:00:35.379 -- 00:00:38.002 Relations section of the company's website. 00:00:38.002 -- 00:00:41.426 Management's prepared remarks and answers to your questions on today's call will contain 00:00:41.426 -- 00:00:45.131 forward-looking statements. These forward-looking statements represent management estimates 00:00:45.131 -- 00:00:49.272 based on current views, expectations, and assumptions, which may prove to be incorrect. 00:00:49.272 -- 00:00:52.597 As a result, matters discussed in any forward-looking statements are subject to risks, 00:00:52.597 -- 00:00:56.784 uncertainties, and changes in circumstances that may cause actual results to differ from 00:00:56.784 -- 00:00:59.849 those described in the forward-looking statements. 00:00:59.849 -- 00:01:02.753 The company assumes no obligation to update any of the forward-looking statements it 00:01...